Results for 'liver cancer'
Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
City of Hope, Academic Research, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…
Mar 9th • 42 mins listen
Monty Pal
At the Crossroads of Cancer and Metabolism
City of Hope, Monty Pal, Charles Brenner, metabolism, diabetes, obesity, fatty liver, metabolic dysfunction, GLP-1, FGF21, NAD metabolism
Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.
Jul 7th • 37 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Monty Pal
Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.
City of Hope, Academic Research, CAR T-cell, Solid Tumor, Glioblastoma, brain tumor
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Christine Brown, Ph.D., Deputy Director of the T Cell Research Laboratory at City of Hope, joins Monty Pal, M.D., F.A.S.C.O., to discuss how years of research in glioblastoma, one of the most aggressive and difficult brain ca…
Apr 6th • 42 mins listen
Monty Pal
Rewriting the Rules of Cellular Therapy
City of Hope, Monty Pal, Stephen Forman, hematologic malignancy, cellular immunotherapy, bone marrow, CAR-T cell therapy
Dr. Stephen Forman shares the past, present, and future of cellular therapy and how City of Hope is building care systems to reach more patients.
Jul 21st • 47 mins listen
Rebecca Previs
Navigating the Future of CDXs in Oncology
Rebecca Previs, Dawn McHugh, Labcorp, precision oncology, companion diagnostics, CDx, biomarker, precision medicine
CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
Feb 18th • 26 mins listen
Michael Pietrack
Season 2, Episode 21: A Century of X-Rays with Margaret Yu
In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care. Dr. Yu unpacks the 130-year history of radiation in medi…
Oct 27th • 20 mins listen
Cancer Buzz Podcast
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…
Jun 25th • 8 mins listen
The Oncology Nursing Podcast
Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon
ONS members Meghan Coleman, DNP, CRNP, and Alison McDaniel, BSN, RN, OCN®, join Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss their Evidence-Based Quality Understanding in Pathology (EQUIP) project to solve unequal access to germline and s…
Dec 24th • 46 mins listen